COMPARATIVE EVALUATION OF NEW TREATMENTS FOR IMMUNE THROMBOCYTOPENIA

Abstract

 The article gives a brief overview of what disease is immune thrombocytopenia, the causes of its origin. Treatment methods were also analyzed and their level was studied. A brief critical evaluation was given for immune thrombocytopenia (ITP) based on a firm and direct assessment of the first and course of treatment. Based on the objective data tested in high-quality clinics, it was concluded that it was necessary to introduce new treatment strategies with better efficacy.